The Medspa Procurement Playbook: Cut Costs, Not Corners

Executive summary#

Most medspas do not have a supply cost problem so much as a visibility problem. Orders are placed by whoever notices the shelf is low, invoices arrive from half a dozen suppliers in different formats, and nobody can say with confidence what the practice pays per usable unit of anything. The result is predictable: duplicate orders, small-order shipping fees, stranded manufacturer rewards, expired stock and, occasionally, a tempting offer from a source that should never have been considered.

This playbook replaces that with a simple procurement system you can run in a few hours a quarter. It starts from an honest premise: not every line on your invoice has the same savings potential. Branded neurotoxins and dermal fillers are priced largely by their manufacturers, and the right move there is to manage program terms and waste, not to hunt for a cheaper seller. The long tail of consumables, PPE and supplies is where competition among authorized suppliers is real, and where disciplined comparison pays off.

Safety is not a trade-off in this playbook. Every framework below treats supplier authorization as a pass/fail gate that comes before price.

What's inside#

• Where savings actually exist: a category-by-category view of who sets the price and which levers you control (this section is free to read below).
• Spend map worksheet: a template to categorize a year of invoices and calculate effective unit cost, with a worked hypothetical example.
• Savings lever matrix: the specific actions that move cost in each category, and the ones that carry risk.
• Supplier scorecard: a weighted, printable rubric with a pass/fail authorization gate.
• Quarterly price-review process: a repeatable calendar, RFQ checklist and decision rules.
• Approval and budget policy template: sample policy language with thresholds you fill in.
• Invoice audit checklist: twenty checks to run before you pay.
• KPI set: definitions and formulas for the numbers worth tracking.
• 30/60/90-day action plan to put it all in place.

Where medspa savings actually exist (and where they don't)#

Before you negotiate anything, sort your spend into four categories. They behave differently, and treating them the same is a common and expensive mistake.

1. Branded injectables: toxins and fillers#

Neurotoxins and hyaluronic acid fillers are usually a medspa's largest supply line, and they are the category where price shopping delivers the least. The major aesthetic manufacturers sell directly to practices through their own ordering portals and structure pricing around their own programs. Allergan Aesthetics, for example, directs practices to order and manage invoices through its Allergan Advantage portal and describes Allergan Partner Privileges as its customer loyalty program alongside the Allē patient program. Those programs change: the American Med Spa Association documented in 2024 how changes to Allē shifted rewards toward free product rather than financial rebates, which altered the economics for practices.

What this means in practice:

• Price differences between authorized channels for the same branded product are usually narrow. Where they exist, they tend to reflect program tiers, promotions, bundles or shipping, not a fundamentally different price.
• Your real levers are program management: which tier you qualify for, whether you are leaving rewards or free goods unclaimed, whether you are buying at the right point in a promotional cycle, and whether reconstituted or opened product is being wasted.
• A dramatically lower price is a red flag. FDA has repeatedly warned that products bought from unauthorized sources "may be unapproved, misbranded, adulterated, counterfeit, contaminated, improperly stored and transported, ineffective and/or unsafe." In 2024 FDA alerted clinicians to counterfeit Botox found in multiple states, and in November 2025 it announced 18 warning letters to websites illegally marketing unapproved botulinum toxin products. FDA also tells providers not to buy dermal fillers online and to inspect filler packaging for authenticity.

This is also the category where Pink Kiwi does not make clinical-interchangeability claims. One toxin or filler is not a substitute for another; that is a clinical decision for your medical director.

2. Clinical consumables and supplies#

Syringes, needles, cannulas, gloves, gauze, alcohol prep pads, sharps containers, drapes, PPE, headbands and similar items are the long tail. Individually they look small. Together, and ordered repeatedly from whichever supplier is convenient, they are where most avoidable spend hides.

This category is genuinely competitive. Many authorized medical-surgical distributors carry the same manufacturer item under the same part number, so you can compare like with like. Savings come from consolidating orders to clear free-shipping thresholds, choosing pack sizes that match your usage, avoiding convenience purchases at retail-style pricing, and re-quoting periodically.

3. Professional skincare#

Medical-grade skincare usually runs through brand-authorized professional accounts, often with minimum advertised price (MAP) policies for retail and separate pricing for back-bar sizes. Savings levers are opening-order and reorder minimums, promotional windows, and not overstocking retail SKUs that expire or go out of style. Buying from unauthorized resellers can void brand support and raises authenticity questions.

4. Devices and device consumables#

Lasers, energy devices and their proprietary tips, cartridges and service contracts are negotiated differently: large capital decisions, multi-year service agreements and consumables that often only the device manufacturer supplies. The leverage is at purchase and renewal time: service terms, consumable pricing locked into the contract, training and uptime commitments.

Summary table#

The rest of this playbook turns that map into a system: a worksheet to see your own numbers, a scorecard to choose suppliers, a quarterly rhythm to keep prices honest, and the policies that stop leakage between reviews.